12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Company News  |  Other News

Shang Pharma supply/service news

ShangPharma appointed independent director Yuk Lam Lo as chairman of the committee formed to review a non-binding acquisition proposal letter from the Chinese CRO's CEO and Chairman Michael Xin Hui and investor TPG...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >